Journal article
Comprehensive Integrated Analysis Reveals the Spatiotemporal Microevolution of Cancer Cells in Patients with Bone-Metastatic Prostate Cancer
- Abstract:
- Background/Objectives: Bone metastasis is a frequent and life-threatening event in advanced cancers, affecting up to 70–85% of prostate cancer patients. Understanding the cellular and molecular mechanisms underlying bone metastasis is essential for developing targeted therapies. This study aimed to systematically characterize the heterogeneity and microenvironmental adaptation of prostate cancer bone metastases using single-cell transcriptomics. Methods: We integrated the largest single-cell transcriptome dataset to date, encompassing 124 samples from primary prostate tumors, various bone metastatic sites, and non-malignant tissues (e.g., benign prostatic hyperplasia, normal bone marrow). After quality control, 602,497 high-quality single-cell transcriptomes were analyzed. We employed unsupervised clustering, gene expression profiling, mutation analysis, and metabolic pathway reconstruction to characterize cancer cell subtypes and tumor microenvironmental remodeling. Results: Cancer epithelial cells dominated the tumor microenvironment but exhibited pronounced heterogeneity, posing challenges for conventional clustering methods. By integrating genetic and metabolic features, we revealed key evolutionary trajectories of epithelial cancer cells during metastasis. Notably, we identified a novel epithelial subpopulation, NEndoCs, characterized by unique differentiation patterns and distinct spatial distribution across metastatic niches. We also observed significant metabolic reprogramming and recurrent mutations linked to prostate-to-bone microenvironmental transitions. Conclusions: This study comprehensively elucidates the mutation patterns, metabolic reprogramming, and microenvironment adaptation mechanisms of bone metastasis in prostate cancer, providing key molecular targets and clinical strategies for the precise treatment of bone metastatic prostate cancer.
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Access Document
- Files:
-
-
(Preview, Version of record, pdf, 7.3MB, Terms of use)
-
- Publisher copy:
- 10.3390/biomedicines13040909
Authors
+ National Natural Science Foundation of China
More from this funder
- Funder identifier:
- https://ror.org/01h0zpd94
- Grant:
- 81972400
- 82202962
+ National Key Research and Development Program of China
More from this funder
- Grant:
- 2022YFE0200800
- 2023YFC2507000
+ Chinese Academy of Medical Sciences Initiative for Innovative Medicine
More from this funder
- Grant:
- 2021-12M-1-015
- 2022-12M-2-002
- 2023-12M-QJ-006
- 2022I2M-1-008
- Publisher:
- MDPI
- Journal:
- Biomedicines More from this journal
- Volume:
- 13
- Issue:
- 4
- Pages:
- 909-909
- Publication date:
- 2025-04-09
- DOI:
- EISSN:
-
2227-9059
- ISSN:
-
2227-9059
- Language:
-
English
- Keywords:
- Pubs id:
-
2329593
- Local pid:
-
pubs:2329593
- Source identifiers:
-
W4409326752
- Deposit date:
-
2025-11-20
- ARK identifier:
This ORA record was generated from metadata provided by an external service. It has not been edited by the ORA Team.
Terms of use
- Copyright date:
- 2025
- Licence:
- CC Attribution (CC BY)
If you are the owner of this record, you can report an update to it here: Report update to this record